口腔与口咽癌手术引流液生物标志物与患者结局的关联
这项前瞻性队列研究纳入2011年4月1日至2016年2月1日在三级或学术医疗中心接受手术的20例口腔与口咽鳞状细胞癌患者(其中14例为IV期),检测术后引流液中细胞因子与基质金属蛋白酶(MMP)水平。结果发现MMP-1、MMP-3与sFlt-1水平与复发相关,血管内皮生长因子A亚型与淋巴结转移相关,碱性成纤维细胞生长因子与淋巴血管侵犯相关,但无生物标志物与疾病结局相关。
要点
- MMP-1、MMP-3与sFlt-1水平与口腔及口咽鳞癌复发相关。
- 血管内皮生长因子A亚型与淋巴结转移相关,碱性成纤维细胞生长因子与淋巴血管侵犯相关。
- 未发现与疾病结局相关的生物标志物,作者认为手术引流液检测可能成为评估预后的新途径。
核心结论
- 在这组口腔与口咽鳞状细胞癌先导样本中,伤口引流液MMP-1、MMP-3与sFlt-1水平与以复发为表现的较差临床肿瘤结局相关。
- 作者认为,这是首份在手术引流液中报告此类发现的研究,引流液是易于获取的细胞因子检测途径。
- 作者认为,手术液中检测这些生物标志物可能代表评估该人群癌症预后的一种新途径。
研究设计与样本
- 前瞻性队列研究,纳入2011年4月1日至2016年2月1日在三级或学术医疗中心需手术治疗的口腔与口咽鳞状细胞癌患者。
- 共20例患者完成标本采集,其中14例为IV期疾病;15例男性、5例女性,平均(SD)年龄63.5(9.9)岁。
- 患者按标准治疗行手术并置入引流管,术后每8小时采集引流液直至按临床标准拔管。
- 采用电化学发光、图案化阵列、多重技术检测细胞因子与基质金属蛋白酶水平。
主要发现
- 复发与MMP-1水平相关,组间相对差异为2.78(95%CI,1.23-6.29)。
- 复发与MMP-3水平相关,组间相对差异为5.29(95%CI,2.14-13.05)。
- 复发与sFlt-1水平相关,组间相对差异为3.75(95%CI,1.84-7.65)。
- 无生物标志物与疾病结局相关。
- 血管内皮生长因子A亚型与淋巴结转移相关,组间相对差异为1.98(95%CI,1.12-3.51);碱性成纤维细胞生长因子与淋巴血管侵犯相关,组间相对差异为1.74(95%CI,1.02-2.97)。
关键数值与推荐
- 检测的生物标志物包括碱性成纤维细胞生长因子、血管内皮生长因子A亚型、可溶性fms样酪氨酸激酶-1(sFlt-1)、胎盘生长因子(PlGF)以及MMP-1、MMP-3、MMP-9。
- 引流液采集频率为术后每8小时一次,直至按临床标准拔除引流管。
- 主要临床结局指标为生存结局与复发。
临床怎么用
- 原文未据此给出临床推荐。
- 作者认为,手术液中检测这些生物标志物可能代表评估该人群癌症预后的一种新途径。
局限性
- 原文称该研究为先导样本(pilot sample)。
- 原文称据作者所知,这是首份在手术引流液中报告此类发现的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Survival rates for head and neck cancer have been relatively stable for several decades. Individualized prognostic indicators are needed to identify patients at risk for poorer outcomes. OBJECTIVE: To determine whether biomarker levels in surgical drain fluid of patients with head and neck cancer are associated with poor cancer outcomes. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study enrolled patients with squamous cell carcinoma (SCC) of the oral cavity and oropharynx who required surgical treatment from April 1, 2011, to February 1, 2016, at a tertiary or academic care center. Twenty patients, including 14 with stage IV disease, had complete specimen collection. Differences in cytokine and MMP levels by disease outcomes were evaluated. INTERVENTIONS: Patients underwent surgical treatment with drain placement as dictated by the standard of care. Drain fluid samples were collected every 8 hours postoperatively until drains were removed because of clinical criteria. Levels of cytokines and matrix metalloproteinases (MMPs) were measured using electrochemiluminescent, patterned array, multiplex technology. MAIN OUTCOMES AND MEASURES: The primary clinical outcome measures were survival outcome and recurrence. The biomarkers measured included the cytokines basic fibroblastic growth factor, vascular endothelial growth factor isoform A, soluble fms-like tyrosine kinase-1 (sFlt-1), and placental growth factor (PIGF) and MMP-1, MMP-3, and MMP-9. Other clinical and pathologic cancer characteristics were recorded. RESULTS: In this cohort of 20 patients with SCC (15 men and 5 women; mean [SD] age, 63.5 [9.9] years), a significant association with recurrence was found for levels of MMP-1 (relative difference between groups, 2.78; 95% CI, 1.23-6.29), MMP-3 (relative difference between groups, 5.29; 95% CI, 2.14-13.05), and sFlt-1 (relative difference between groups, 3.75; 95% CI, 1.84-7.65). No biomarkers were associated with disease outcome. Vascular endothelial growth factor isoform A was associated with nodal metastasis (relative difference between groups, 1.98; 95% CI, 1.12-3.51), and basic fibroblastic growth factor was associated with lymphovascular invasion (relative difference between groups, 1.74; 95% CI, 1.02-2.97). CONCLUSIONS AND RELEVANCE: In this pilot sample of patients with SCC of the oral cavity and oropharynx, MMP-1, MMP-3, and sFlt-1 levels in wound fluid were associated with poor clinical cancer outcomes in the form of recurrence. This finding is consistent with the literature of tumor microenvironment in saliva, serum, and tumor tissue biomarkers. To our knowledge, this report is the first of such findings in surgical drain fluid, an easily accessible means of cytokine measurement. Measurement of these biomarkers in surgical fluid potentially represents a novel means of assessing cancer prognosis in this population.
引用
- Lassig AAD, Joseph AM, Lindgren BR, et al. Association of Oral Cavity and Oropharyngeal Cancer Biomarkers in Surgical Drain Fluid With Patient Outcomes. JAMA Otolaryngol Head Neck Surg. 2017. PMID: 28418447. doi:10.1001/jamaoto.2016.3595
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。